BRPI0614867A2 - chimeric antibody or antigen-binding portion thereof, method for producing a chimeric antibody or antigen-binding portion thereof, and kit - Google Patents

chimeric antibody or antigen-binding portion thereof, method for producing a chimeric antibody or antigen-binding portion thereof, and kit Download PDF

Info

Publication number
BRPI0614867A2
BRPI0614867A2 BRPI0614867A BRPI0614867A2 BR PI0614867 A2 BRPI0614867 A2 BR PI0614867A2 BR PI0614867 A BRPI0614867 A BR PI0614867A BR PI0614867 A2 BRPI0614867 A2 BR PI0614867A2
Authority
BR
Brazil
Prior art keywords
antigen
chimeric antibody
binding portion
kit
producing
Prior art date
Application number
Other languages
Portuguese (pt)
Inventor
Philip Anthony Jennings
Anthony Gerard Doyle
Adam William Clarke
Original Assignee
Arana Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to AU2005904406A priority Critical patent/AU2005904406A0/en
Application filed by Arana Therapeutics Ltd filed Critical Arana Therapeutics Ltd
Priority to PCT/AU2006/001166 priority patent/WO2007019621A1/en
Publication of BRPI0614867A2 publication Critical patent/BRPI0614867A2/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/20Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/50Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/565Complementarity determining region [CDR]

Abstract

ANTICORPO QUIMéRICO OU UMA PORçãO DE LIGAçãO DE ANTìGENO DO MESMO, MéTODO PARA PRODUZIR UM ANTICORPO QUIMéRICO OU UMA PORçãO DE LIGAçãO DE ANTìGENO DO MESMO, E, KIT. Chimeric antibody or a portion of EVEN antigen CONNECTION, METHOD FOR PRODUCING AN ANTIBODY Chimeric or a portion of THE SAME antigen-binding, and, KIT. A presente invenção provê um anticorpo quimérico ou uma porção de ligação de antígeno do mesmo. The present invention provides a chimeric antibody or a portion of the same antigen binding. A porção de ligação de antígeno compreende pelo menos duas regiões de determinação da complementaridade (CDR) e pelo menos três regiões de estrutura, em que pelo menos uma CDR é uma CDR de primata do Novo Mundo. The antigen-binding portion comprises at least two complementarity determining regions (CDRs) and at least three framework regions, wherein at least one CDR is a New World primate CDR.
BRPI0614867 2005-08-15 2006-08-15 chimeric antibody or antigen-binding portion thereof, method for producing a chimeric antibody or antigen-binding portion thereof, and kit BRPI0614867A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AU2005904406A AU2005904406A0 (en) 2005-08-15 New World Antibodies
PCT/AU2006/001166 WO2007019621A1 (en) 2005-08-15 2006-08-15 Chimeric antibodies with new world primate regions

Publications (1)

Publication Number Publication Date
BRPI0614867A2 true BRPI0614867A2 (en) 2012-01-31

Family

ID=37757238

Family Applications (2)

Application Number Title Priority Date Filing Date
BRPI0614867 BRPI0614867A2 (en) 2005-08-15 2006-08-15 chimeric antibody or antigen-binding portion thereof, method for producing a chimeric antibody or antigen-binding portion thereof, and kit
BRPI0614430 BRPI0614430A2 (en) 2005-08-15 2006-08-15 antibody or antigen-binding portion thereof, and kit

Family Applications After (1)

Application Number Title Priority Date Filing Date
BRPI0614430 BRPI0614430A2 (en) 2005-08-15 2006-08-15 antibody or antigen-binding portion thereof, and kit

Country Status (13)

Country Link
EP (1) EP1945669A4 (en)
JP (1) JP2009504686A (en)
KR (1) KR20080068005A (en)
CN (2) CN101287762A (en)
AU (1) AU2006281981A1 (en)
BR (2) BRPI0614867A2 (en)
CA (1) CA2619245A1 (en)
MX (1) MX2008002161A (en)
NO (1) NO20080800L (en)
NZ (1) NZ565904A (en)
RU (1) RU2008110058A (en)
WO (1) WO2007019621A1 (en)
ZA (2) ZA200802246B (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1791563A4 (en) 2004-07-26 2009-07-08 Biogen Idec Inc Anti-cd154 antibodies
JP5259423B2 (en) 2006-02-01 2013-08-07 セファロン・オーストラリア・ピーティーワイ・リミテッド Domain antibody construct
RS58518B1 (en) * 2007-03-22 2019-04-30 Biogen Ma Inc Binding proteins, including antibodies, antibody derivatives and antibody fragments, that specifically bind cd154 and uses thereof
WO2010017595A1 (en) * 2008-08-14 2010-02-18 Arana Therapeutics Limited Variant domain antibodies
RU2519862C2 (en) * 2010-08-06 2014-06-20 Олег Ильич Эпштейн Complex medication and method of prevention and treatment of infectious viral diseases
RU2502521C2 (en) * 2010-08-06 2013-12-27 Олег Ильич Эпштейн Combined drug for treating bacterial infections and method of treating bacterial infections
RU2535033C2 (en) * 2010-08-06 2014-12-10 Олег Ильич Эпштейн Therapeutic agent and method for prevention of hiv infection and treatment of hiv-caused or hiv-associated diseases, including aids
RU2505312C2 (en) * 2010-08-06 2014-01-27 Олег Ильич Эпштейн Combined therapeutic agent for treating various types of influenza
RU2521392C2 (en) * 2010-08-06 2014-06-27 Олег Ильич Эпштейн Combined drug for treating viral infections and method of treating viral infections
RU2517085C2 (en) * 2010-08-06 2014-05-27 Олег Ильич Эпштейн Complex medication and method of preventing hiv infection, prevention and treatment of hiv-induced and hiv-associated diseases, including aids
RU2516931C2 (en) * 2010-08-06 2014-05-20 Олег Ильич Эпштейн Method and composition for preventing hiv infection, preventing and treating hiv-caused or hiv-associated diseases, including aids
RU2535034C2 (en) * 2010-08-06 2014-12-10 Олег Ильич Эпштейн Medication and method of preventing hiv infection, prevention and treatment of hiv-induced or hiv-associated diseases, including aids
RU2577299C2 (en) * 2011-07-04 2016-03-10 Олег Ильич Эпштейн Method for treating infectious diseases and complex medication for treatment of infectious diseases
RU2579262C1 (en) * 2014-10-02 2016-04-10 Мапикс Эс.Эй.Ар.Эл. Medicinal agent for treating infectious diseases

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1715045A3 (en) * 1991-07-25 2006-12-13 Biogen Idec Inc. Recombinant antibodies for human therapy
US6569431B2 (en) * 2000-10-17 2003-05-27 The Regents Of The University Of California Recombinant antibody fragments as autoantibody antagonists
US7235643B2 (en) * 2000-11-07 2007-06-26 Morphotek, Inc. Antibodies and methods for generating genetically altered antibodies with high affinity
PT1517921E (en) * 2002-06-28 2006-09-29 Domantis Ltd Differently specified ligands with semi-life in the increased serum
US20070212301A1 (en) * 2003-11-07 2007-09-13 Amgen, Inc. Monkey Immunoglobulin Sequences

Also Published As

Publication number Publication date
EP1945669A1 (en) 2008-07-23
WO2007019621A1 (en) 2007-02-22
CA2619245A1 (en) 2007-02-22
KR20080068005A (en) 2008-07-22
NZ565904A (en) 2012-02-24
EP1945669A4 (en) 2009-07-22
JP2009504686A (en) 2009-02-05
AU2006281981A1 (en) 2007-02-22
NO20080800L (en) 2008-05-09
RU2008110058A (en) 2009-09-27
CN101287763A (en) 2008-10-15
MX2008002161A (en) 2008-04-22
ZA200802247B (en) 2009-08-26
BRPI0614430A2 (en) 2011-03-29
CN101287762A (en) 2008-10-15
ZA200802246B (en) 2009-09-30

Similar Documents

Publication Publication Date Title
RU2483080C2 (en) Antibodies and immunoconjugates and their application
ES2527961T3 (en) human monoclonal antibodies to CD70
ES2505144T3 (en) Selective binding agents antagonists osteoprotegerin binding protein
ES2523740T3 (en) Monoclonal antibodies to the receptor of fibroblast growth factor 2
DE602004028863D1 (en) Related leg extensions for an endoluminal prosthesis-
MXPA06002890A (en) Anti-glypican 3 antibody.
RS53685B1 (en) Human anti-il-23 antibodies, compositions, methods and uses
NZ585627A (en) Bivalent, bispecific antibodies
NZ614857A (en) Bispecific antibodies and methods for production thereof
RU2012101485A (en) Bispecific tetravalent antigen-binding protein
NO20050101D0 (en) Sulfur scavengers and methods for making and overusing Sami
TR201810005T4 (en) IL-4 and / or IL-13 binding antibodies and their use.
DE602005021597D1 (en) Sealing arrangement for trocar
NZ602780A (en) Human antibodies that bind lymphocyte activation gene-3 (lag-3), and uses thereof
NZ712765A (en) Antibodies that bind csf1r
WO2002096948A3 (en) Engineered tetravalent antibodies and methods of use
WO2001090190A3 (en) Single-domain antigen-binding antibody fragments derived from llama antibodies
RU2010120674A (en) Fully human anti-vegf-antibodies and methods for their use
NZ548702A (en) Antibodies to MAdCAM
MXPA05005921A (en) Antibodies directed to tumor necrosis factor and uses thereof.
RU2007142444A (en) Improved nanobodies against tumor necrosis factor-alpha tumor
TR201808535T4 (en) antigen binding again capable of binding two or more molecules of antigen molecules.
DE602006008521D1 (en) Toner and developer
SG151284A1 (en) Antibodies against ccr5 and uses thereof
ECSP10010297A (en) bivalent bispecific antibodies

Legal Events

Date Code Title Description
B25D Entry of change of name and/or headquarter and transfer of application, patent and certificate of addition of invention: change of name granted

Owner name: ARANA THERAPEUTICS PTY LTD. (AU)

Free format text: NOME ALTERADO DE: ARANA THERAPEUTICS LIMITED

B25D Entry of change of name and/or headquarter and transfer of application, patent and certificate of addition of invention: change of name granted

Owner name: CEPHALON AUSTRALIA PTY LTD. (AU)

Free format text: NOME ALTERADO DE: ARANA THERAPEUTICS PTY LTD.

B06F Objections, documents and/or translations needed after an examination request according art. 34 industrial property law
B08F Application fees: dismissal - article 86 of industrial property law

Free format text: REFERENTE A 7A ANUI DADE.

B08K Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87)

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2214 DE 11/06/2013.